BIOTECanada welcomes the announcement of the Pharmaceutical and Life Sciences Sector Task Force and the clear recognition that a strong life sciences sector is essential to both economic growth and health outcomes in Canada. This work should remain focused on the investment and regulatory conditions needed to grow globally competitive companies, and – most importantly – improving patient access to innovative therapies.